Phosphate Binders in CKD: ‟New Kids on the Block”
DOI:
https://doi.org/10.53778/pjkd31089Trefwoorden:
hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxideSamenvatting
Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.
Downloads
Gepubliceerd
Nummer
Sectie
Licentie
Auteursrecht (c) 2021 Muhammad Umair Afzal, Shafeeq Cheema

Dit artikel is gelicentieerd onder de Naamsvermelding-NietCommercieel 4.0 Internationaal licentie.
